Please use this identifier to cite or link to this item:
Title: Serum phospholipidomics reveals altered lipid profile and promising biomarkers in multiple sclerosis
Author: Ferreira, Helena Beatriz
Melo, Tânia
Monteiro, Andreia
Paiva, Artur
Domingues, Pedro
Domingues, M. Rosário
Keywords: Multiple sclerosis
Mass spectrometry
Lipid profile
Issue Date: 15-Jan-2021
Publisher: Elsevier
Abstract: Multiple sclerosis is a neurodegenerative disease causing disability in young adults. Alterations in metabolism and lipid profile have been associated with this disease. Several studies have reported changes in the metabolism of arachidonic acid and the profile of fatty acids, ceramides, phospholipids and lipid peroxidation products. Nevertheless, the understanding of the modulation of circulating lipids at the molecular level in multiple sclerosis remains unclear. In the present study, we sought to assess the existence of a distinctive lipid signature of multiple sclerosis using an untargeted lipidomics approach. It also aimed to assess the differences in lipid profile between disease status (relapse and remission). For this, we used hydrophilic interaction liquid chromatography coupled with mass spectrometry for phospholipidomic profiling of serum samples from patients with multiple sclerosis. Our results demonstrated that multiple sclerosis has a phospholipidomic signature different from that of healthy controls, especially the PE, PC, LPE, ether-linked PE and ether-linked PC species. Plasmalogen PC and PE species, which are natural endogenous antioxidants, as well as PC and PE polyunsaturated fatty acid esterified species showed significantly lower levels in patients with multiple sclerosis and patients in both remission and relapse of multiple sclerosis. Our results show for the first time that the serum phospholipidome of multiple sclerosis is significantly different from that of healthy controls and that few phospholipids, with the lowest p-value, such as PC(34:3), PC(36:6), PE(40:10) and PC(38:1) may be suitable as biomarkers for clinical applications in multiple sclerosis.
Peer review: yes
DOI: 10.1016/
ISSN: 0003-9861
Appears in Collections:CESAM - Artigos
DQ - Artigos
QOPNA - Artigos
REQUIMTE - Artigos

Files in This Item:
File Description SizeFormat 
Serum phospholipidomics reveals altered lipid profile and promising biomarkers in.pdf1.95 MBAdobe PDFView/Open

Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.